For the readers interested in the stock health of Dare Bioscience Inc. (DARE). It is currently valued at $1.45. When the transactions were called off in the previous session, Stock hit the highs of $1.4899, after setting-off with the price of $1.48. Company’s stock value dipped to $1.42 during the trading on the day. When the trading was stopped its value was $1.42.Recently in News on July 26, 2021, Daré Bioscience to Present at the 2021 Controlled Release Society Virtual Annual Meeting to be held July 25-29, 2021. Presentation will highlight the positive topline results from the DARE-BVFREE Phase 3 randomized, double-blinded, placebo-controlled clinical trial evaluating Daré’s product candidate DARE-BV1 in women diagnosed with bacterial vaginosis. You can read further details here
Dare Bioscience Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.8500 on 01/20/21, with the lowest value was $1.2000 for the same time period, recorded on 05/26/21.
Dare Bioscience Inc. (DARE) full year performance was 15.45%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Dare Bioscience Inc. shares are logging -62.34% during the 52-week period from high price, and 53.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.94 and $3.85.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1088983 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Dare Bioscience Inc. (DARE) recorded performance in the market was 5.97%, having the revenues showcasing -7.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 69.57M, as it employees total of 23 workers.
Specialists analysis on Dare Bioscience Inc. (DARE)
During the last month, 0 analysts gave the Dare Bioscience Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.5516, with a change in the price was noted -0.49. In a similar fashion, Dare Bioscience Inc. posted a movement of -25.00% for the period of last 100 days, recording 5,312,822 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DARE is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Dare Bioscience Inc. (DARE)
Raw Stochastic average of Dare Bioscience Inc. in the period of last 50 days is set at 20.40%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 3.40%. In the last 20 days, the company’s Stochastic %K was 5.66% and its Stochastic %D was recorded 6.80%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 5.97%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -45.17%, alongside a boost of 15.45% for the period of the last 12 months. The shares increased approximately by -5.33% in the 7-day charts and went up by -15.98% in the period of the last 30 days. Common stock shares were lifted by -7.79% during last recorded quarter.